76 related articles for article (PubMed ID: 10935259)
1. [Scales for functional assessment in multiple sclerosis].
Prieto-González JM
Rev Neurol; 2000 Jun 16-30; 30(12):1246-52. PubMed ID: 10935259
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of multiple sclerosis: quantification by use of scales].
Izquierdo G; Ruiz-Peña JL
Rev Neurol; 2003 Jan 16-31; 36(2):145-52. PubMed ID: 12589602
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome measures in multiple sclerosis.
Amato MP; Portaccio E
J Neurol Sci; 2007 Aug; 259(1-2):118-22. PubMed ID: 17376487
[TBL] [Abstract][Full Text] [Related]
4. The psychometric properties of clinical rating scales used in multiple sclerosis.
Sharrack B; Hughes RA; Soudain S; Dunn G
Brain; 1999 Jan; 122 ( Pt 1)():141-59. PubMed ID: 10050902
[TBL] [Abstract][Full Text] [Related]
5. [Impairment, disability and handicap scales in multiple sclerosis].
Arbizu-Urdiain T; Martínez-Yélamos A; Casado Ruiz V
Rev Neurol; 2002 Dec 1-15; 35(11):1081-93. PubMed ID: 12497316
[TBL] [Abstract][Full Text] [Related]
6. Refining an automatic EDSS scoring expert system for routine clinical use in multiple sclerosis.
Gaspari M; Saletti D; Scandellari C; Stecchi S
IEEE Trans Inf Technol Biomed; 2009 Jul; 13(4):501-11. PubMed ID: 19273014
[TBL] [Abstract][Full Text] [Related]
7. Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample.
Idiman E; Uzunel F; Ozakbas S; Yozbatiran N; Oguz M; Callioglu B; Gokce N; Bahar Z
J Neurol Sci; 2006 Jan; 240(1-2):77-80. PubMed ID: 16277993
[TBL] [Abstract][Full Text] [Related]
8. [Pentoxifylline: is it useful in multiple sclerosis?].
Prieto JM; Dapena D; Lema M; Ares B; Cacabelos P; Noya M
Rev Neurol; 2001 Mar 16-31; 32(6):529-31. PubMed ID: 11353990
[TBL] [Abstract][Full Text] [Related]
9. [Prospective assessment of the treatment of multiple sclerosis relapses with oral high-dose methylprednisolone: response and tolerability data].
Pascual AM; Boscá I; Escutia M; Bernat A; Coret F; Casanova B
Neurologia; 2008 Mar; 23(2):73-7. PubMed ID: 17641984
[TBL] [Abstract][Full Text] [Related]
10. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis.
Ozakbas S; Cagiran I; Ormeci B; Idiman E
J Neurol Sci; 2004 Mar; 218(1-2):3-7. PubMed ID: 14759626
[TBL] [Abstract][Full Text] [Related]
11. The development and validation of the impact of multiple sclerosis scale and the symptoms of multiple sclerosis scale.
McMillan L; Moore KA
Arch Phys Med Rehabil; 2006 Jun; 87(6):832-41. PubMed ID: 16731220
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of handicap and socio-economic status in patients with multiple sclerosis--data from a population-based survey in the sanitary area of Calatayud, northern Spain.
Pina Latorre MA; Ara JR; Modrego PJ; Martín M
Wien Med Wochenschr; 2001; 151(9-10):224-7. PubMed ID: 11475098
[TBL] [Abstract][Full Text] [Related]
13. Validity of performance scales for disability assessment in multiple sclerosis.
Marrie RA; Goldman M
Mult Scler; 2007 Nov; 13(9):1176-82. PubMed ID: 17623733
[TBL] [Abstract][Full Text] [Related]
14. Costs and quality of life of multiple sclerosis in Austria.
Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
[TBL] [Abstract][Full Text] [Related]
15. Use of low-dose mitozantrone to treat aggressive multiple sclerosis: a single-centre open-label study using patient self-assessment and clinical measures of multiple sclerosis status.
Ostberg A; Pittas F; Taylor B
Intern Med J; 2005 Jul; 35(7):382-7. PubMed ID: 15958106
[TBL] [Abstract][Full Text] [Related]
16. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.
Roxburgh RH; Seaman SR; Masterman T; Hensiek AE; Sawcer SJ; Vukusic S; Achiti I; Confavreux C; Coustans M; le Page E; Edan G; McDonnell GV; Hawkins S; Trojano M; Liguori M; Cocco E; Marrosu MG; Tesser F; Leone MA; Weber A; Zipp F; Miterski B; Epplen JT; Oturai A; Sørensen PS; Celius EG; Lara NT; Montalban X; Villoslada P; Silva AM; Marta M; Leite I; Dubois B; Rubio J; Butzkueven H; Kilpatrick T; Mycko MP; Selmaj KW; Rio ME; Sá M; Salemi G; Savettieri G; Hillert J; Compston DA
Neurology; 2005 Apr; 64(7):1144-51. PubMed ID: 15824338
[TBL] [Abstract][Full Text] [Related]
17. Costs and quality of life for patients with multiple sclerosis in Belgium.
Kobelt G
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662
[TBL] [Abstract][Full Text] [Related]
18. Validity of six balance disorders scales in persons with multiple sclerosis.
Cattaneo D; Regola A; Meotti M
Disabil Rehabil; 2006 Jun; 28(12):789-95. PubMed ID: 16754576
[TBL] [Abstract][Full Text] [Related]
19. Oropharyngeal dysphagia in amyotrophic lateral sclerosis: neurological and dysphagia specific rating scales.
Kidney D; Alexander M; Corr B; O'toole O; Hardiman O
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5(3):150-3. PubMed ID: 15512903
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic efficacy during active phases of multiple sclerosis: gait analysis and comparison with the EDSS score].
Fauchard-Renard C; Renard JF; Miret N; Hannequin D; Mihout B; Weber J
Rev Neurol (Paris); 2001 Jul; 157(6-7):649-54. PubMed ID: 11458184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
